HMGB1 and neoplasm: Moreover, recent findings have shown that tumor-infiltrating DCs suppress nucleic acid-mediated innate immune responses through interactions between the receptor TIM-3 and the alarmin HMGB1 (68) therefore defining a new mechanism whereby the TME suppresses anti-tumor immunity.